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Abstract
Background: High consumption of antibiotics has been identified as an important driver for the increasing
antibiotic resistance, considered to be one of the greatest threats to public health globally. Simply informing the
public about this consequence is insufficient to induce behavioral change. This study explored beliefs and
perceptions among Swedes, with the aim of identifying factors promoting and hindering a judicious approach to
antibiotics use. The study focused primarily on the medical use of antibiotics, also considering other aspects
connected with antibiotic resistance, such as travelling and food consumption.
Methods: Data were collected through focus group discussions at the end of 2016. Twenty-three Swedes were
recruited using an area-based approach and purposive sampling, aiming for as heterogeneous groups as possible
regarding gender (13 women, 10 men), age (range 20–81, mean 38), and education level. Interview transcripts were
analyzed using qualitative content analysis. The Health Belief Model was used as a theoretical framework.
Results: Antibiotic resistance was identified by participants as a health threat with the potential for terrible
consequences. The severity of the problem was perceived more strongly than the actual likelihood of being
affected by it. Metaphors such as climate change were abundantly employed to describe antibiotic resistance as a
slowly emerging problem. There was a tension between individual (egoistic) and collective (altruistic) reasons for
engaging in judicious behavior. The individual effort needed and antibiotics overprescribing were considered major
barriers to such behavior. In their discussions, participants stressed the need for empowerment, achieved through
good health communication from authorities and family physicians.
Conclusions: Knowledge about antibiotic consumption and resistance, as well as values such as altruism and trust
in the health care system, has significant influence on both perceptions of individual responsibility and on behavior.
This suggests that these factors should be emphasized in health education and health promotion. To instead frame
antibiotic resistance as a slowly emerging disaster, risks diminish the public perception of being susceptible to it.
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Background
Antibiotics are used to treat many community- and
hospital-acquired bacterial infections. They are consid-
ered cornerstones of modern medicine in that they are
needed to prevent and treat infections associated with,
inter alia, cancer and burn treatment, chronic diseases,
device surgery, transplantations and neonatal care [1].
Antibiotic resistance (AR) is a form of drug resistance
where bacteria can survive exposure to antibiotics. It is
an inevitable process, which is speeded up due to human
behavior, as the mere usage of antibiotics enriches and
selects for resistance in humans, animals, and the
environment. The World Health Organization (WHO)
regards the rapid development of multidrug resistant
(MDR) bacteria as one of the most significant threats
to public health globally, as it severely restricts the
possibility of treating infectious diseases [2].
To curb AR, a strategic objective is to improve public
awareness and understanding, WHO says. Other stra-
tegic objectives are to strengthen the knowledge and
evidence base, to reduce the incidence of infection, to
optimize the use of antimicrobial medicines in human
and animal health, and to develop the economic case for
sustainable investment [2]. Improving public awareness
and understanding depends on effective communication,
education and training. Studies suggest that improved
understanding of antibiotics may make people feel and
act more responsibly [3], but, although being a pre-
requisite for judicious behavior, information-giving in
itself might be insufficient to change behavior [4]. Inves-
tigating the perceptions, beliefs and, ultimately, the
public health behavior influencing AR is crucial to iden-
tify where and how to intervene in health education and
health promotion [5].
Containment of AR requires both local and global
strategies to improve public awareness and understand-
ing. We work from the premises that local strategies can
benefit from the investigation of the beliefs and percep-
tions that influence AR and that such investigations
should be sensitive to context and culture. Possible
solutions which may help reducing AR in a country or
population may have limited effects in others. Nonethe-
less, the knowledge generated can of course still be of
use in other contexts.
To explore antibiotics-related beliefs and perceptions
in a country (Sweden), where the public have some
knowledge of AR and comparatively use antibiotics more
responsibly, might increase the understanding of factors
behind judicious and non-judicious approaches to anti-
biotics. In Europe, AR varies widely and is generally
higher in southern and south-eastern Europe than in the
north. In Sweden, consumption of oral antibiotics is
lower than in other European states and the population
knows comparatively more about AR and use antibiotics
more judiciously [6]. Local and national cooperation
characterizes Swedish work on containment of AR and
since 1989 there are County Medical Officers for commu-
nicable disease control. The Swedish Strategic Program
against Antibiotic Resistance (Strama), whose overall aim
is to preserve antibiotics effectiveness, has worked at
regional and national levels since 1994. Starting in 2000
(and extended in 2012), a plan for coordinated work
towards the containment of antibiotic resistance and
healthcare-associated diseases is jointly run by the Na-
tional Board of Health and Welfare and the Swedish
Board of Agriculture. As a result of such early commit-
ments to curb AR, antibiotic consumption started to
decrease already in the 90s [7].
The present study aimed to explore Swedes’ beliefs
about and perceptions of antibiotics, in order to find
which factors promote or hinder a judicious approach to
antibiotics. To our knowledge, while a few studies have
quantitatively investigated the Swedish population [8, 9],
and Swedish travelers qualitatively [10, 11], no previous
qualitative research has been done on public perception
and belief affecting antibiotics-related health behavior.
Methods
Design
A qualitative and explorative design was used to collect
data through focus group discussions (FGDs). FGDs pro-
vide insight into behavior by generating a process that
helps participants to self-disclose [12, 13].
The Health Belief Model (HBM) was used for develop-
ing the interview guide, in the data analysis and the
discussion of the results. HBM is a psychological, theor-
etical model extensively used to explain changes in and
maintenance of health-related behavior, not least for
infectious disease studies [14, 15]. According to the
HBM, personal demographic and psychological char-
acteristics influence how people perceive the serious-
ness of and susceptibility to a disease, as well as
barriers to and benefits of treatment. Each of these
tenets can contribute to an explanation of health
behavior. By weighing these health beliefs against
possible cues for action and the individual’s perceived
self-efficacy, an understanding of health behavior can
be achieved [16, 17]. Table 1 describes how HBM
constructs were applied to this study.
The interview guide was structured according to state
of the art guidelines for focus groups [12]. The guide
was developed by the authors for this study and it was
based on a review of the existing literature investigating
antimicrobial-related awareness, knowledge, attitudes,
beliefs, and behavior.
The structure and themes of the interview were the
following: A) Opening question (introducing oneself and
reasons for participating); B) Introductory question
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(spontaneous thoughts about antibiotics); C) Transition
question (personal experience of antibiotics); D) Key
questions (I - advantages and disadvantages of using an-
tibiotics, II – prescriptions, III - consequences in the
present and in the future of misuse of antibiotics at indi-
vidual and community level, IV - AR, V - individual re-
sponsibility, commitment and cues to action); E) Ending
question (imagining to advise health authorities) (see
Additional file 1).
Follow-up and probing questions were used for clarifi-
cation and elaboration. The research team thoroughly
discussed the interview guide, and after a pilot study, a
few questions were eliminated to reduce participants’ fa-
tigue while key questions were arranged in a more con-
sequent order.
Sampling, recruitment & data collection
Participants were recruited from the general population.
Inclusion criteria: aged over 18 years and proficient in
Swedish. Exclusion criteria: individuals with relevant
healthcare education or professional status. The decision
to exclude these individuals was taken in order to
minimize any individual’s authority affecting the group
dynamics. Participants were recruited by MA in Au-
gust–September 2016 through an area-based approach
and purposive sampling, aiming for as heterogeneous
groups as possible regarding gender, age, and education
level [18]. Participants received a gift card of approxi-
mately EUR 25 after participating.
The FGDs were held in a meeting room at Uppsala
University during October–November 2016. A female
and a male senior lecturer, TG and SE, conducted the
FGDs in Swedish and SE took notes. Participants were
informed about the topic of the discussion. They had no
prior relationship with the interviewers. The FGDs
lasted between 90 and 120 min, including a break. After
30–40 min, participants watched a short video present-
ing basic facts on AR [19]. Data saturation was reached
after three FGDs. The interviews were audio recorded
and transcribed verbatim. No dropouts occurred.
Data analysis
Data were analyzed using a directed approach to qualita-
tive content analysis [20], in QSR International’s NVivo
11 Software. The HBM key constructs were used for the
analysis (see Table 1). MA and TG analyzed the tran-
scripts independently, compared outcomes and dis-
cussed inconsistencies. All authors discussed the results
critically in frequent debriefing sessions and the study
was also subjected to peer scrutiny and an audit trail.
The Consolidated criteria for reporting qualitative stud-
ies (COREQ) was adhered to [21].
Results
Twenty-three members of the general public partici-
pated in four FGDs (see Table 2). All participants were
recruited from Uppsala city and areas nearby.
The results are presented according to the HBM.
Quotes in Table 3 are used to provide evidence of
authors’ interpretations, to offer readers greater depth of
understanding, and to give research participants a voice.
They are abbreviated as Q1, Q2 etc. in the text below.
Perceived seriousness of and susceptibility to AR-related
health issues
All particpants identified AR as a far-reaching health
problem which could have terrible future consequences.
Participants abundantly resorted to metaphors and
analogies to describe the AR problem. An often recur-
ring simile was climate change, compared with regard to
the likelihood of being affected and its seriousness (Q1).
Although all participants acknowledged the threat, a
kind of individual detachment was sometimes detected,
as if only other people could be affected. Moreover, the
doubt was sometimes voiced that individual judicious
behavior might be futile. Participants harbored the idea
that living in Sweden made it less likely that they would
Table 1 Application of Health Belief Model Constructs to antibiotic issues
Construct Application
Perceived susceptibility The participant’s subjective assessment/perception of the likelihood of
being personally affected by antibiotic-resistant bacteria
Perceived seriousness The participant’s assessment/perception of the severity of the situation
regarding antibiotic-resistant bacteria
Perceived benefits The participant’s assessment/perception of the benefits of engaging
in judicious behavior in relation to antibiotics
Perceived barriers The participant’s assessment/perception of barriers to engaging in judicious
behavior in relation to antibiotics
Perceived self-efficacy The participant’s perception of his/her or others’ competence in engaging
in judicious behavior in relation to antibiotics
Cues to action Trigger mechanisms to prompt engagement in judicious behavior
in relation to antibiotic use
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be affected by MDR bacteria (Q2). Accordingly, the per-
ceived susceptibility was greater in relation to visiting
countries with severe antibiotic resistance records; most
mentioned was Thailand, which is a Swedish favorite
holiday destination. Food, typically meat, was probably
the most feared source of MDR bacteria, and often the
dichotomy between Swedish and imported food was
brought up (Q3).
Respondents frequently framed their fears in terms of
possible suffering because of AR and that they may go
untreated in the future because of extreme measures
that could be taken to preserve antibiotic efficacy (Q4).
Perceived benefits and barriers
The most important benefit of engaging in judicious use
of antibiotics was the preservation of antibiotic effective-
ness, both for the individual and the public. This con-
cern also extended to future generations. This positive
view of antibiotics comes with a risk that people get
“spoiled” and demand antibiotics to great quantities or
when it is not really necessary, the respondents pointed
out (Q5). Many participants identified compliance with
prescriptions and restricting personal use of antibiotics
as important measures that would benefit individuals.
This would lower the risk of there being no available
treatment in the future and prompt the body’s immune
system to respond, thus helping to withstand infections.
Using fewer antibiotics, refraining from asking for anti-
biotics, and compliance with prescriptions, would also
place “society first”. If one engages in judicious behavior,
one can still use antibiotics when it is necessary, without
feeling guilty about it (Q6). In the same way, one should
take care to get vaccinated when traveling to countries
with high AR records (Q7).
Considering the barriers, judicious behavior when e.g.
consuming or travelling can conflict with individual
interests as it can involve both individual efforts and
costs (Q8). Other barriers were a perceived lack of inter-
national commitment to the fight against AR and over-
generous prescribing (Q9). Participants reported they
had been able to easily obtain antibiotics while abroad
and many viewed Sweden as being isolated in trying to
act more judiciously (Q10).
Self-efficacy in engaging in judicious behavior and
potential cues to engagement
Participants expressed their willingness to engage in
judicious behavior. They often gave altruistic reasons
and believed that they had duties as individuals to so act
(Q11). They reported good levels of perceived self-effi-
cacy to engage in judicious behavior but still thought
that it might become difficult (Q12). Such engagement
was deemed appropriate only up to the point where life
was threatened.
As to cues to action, participants stated that they
would be more encouraged if their efforts would be part
of a broader, international plan (Q13). It was also a
general opinion that it would be beneficial to involve the
public and that public awareness could be improved.
Participants were quite aware of AR and of the fact that
one should not misuse antibiotics, but were also mark-
edly insecure about AR mechanisms, potential sources
of MDR bacteria, and had many questions concerning
antibiotics use. It was agreed that more communication
from health authorities is needed, but there were
contrasting opinions on the form it should take. A few
participants stated that information about AR should be
frightening (otherwise people would not take it ser-
iously), but the majority felt that a more neutral form of
communication would be more productive. Respondents
trusted their physicians but had misgivings about
communicating with healthcare personnel. They valued
being informed as it is empowering; one can more easily
make informed choices and also be more accepting
when physicians do not prescribe antibiotics (Q14).
Discussion
The most striking results (see Fig. 1) were the prevalent
description of AR as a slowly emerging problem that is
somehow creeping up on us; the presence of a distinct
tension between individual and collective interests; and
the perceived need for empowerment through good
health communication.
Table 2 Demographic information for the 23 participants
G 1 G 2 G 3 G 4
Woman 4 4 3 2 13
Man 3 2 3 2 10
Age
Minimum 20
Mean 38
Maximum 81
Educationa
EQF 4–5 12
EQF 6–7 8
EQF 8 3
Reported history of antibiotic consumption
Never taken 5
Taken at least once 18
Taken last year 4
Taken before last year 14
aEducation was measured as the European Qualifications Framework (EQF)
level. EQF 4–5 indicates high school, vocational school and university
diplomas, EQF 6–7 indicates bachelor’s degree, vocational universities, and
master’s degree, EQF 8 indicates doctoral degree
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A global problem sneaking up on us
The likelihood of being personally affected by AR was
not perceived as high, yet participants were scared by
the prospect of a future without effective antibiotics.
This discrepancy between perceived seriousness of and
perceived susceptibility to AR has previously been re-
ported [11, 22]. Research in risk perception indicates
that lay people consider the severity of materialized risks
as more important than the likelihood of being affected
because they perceive risks differently from experts:
They have a broader notion of risk, incorporating
considerations such as uncertainty, dread, and future
generations [23]. Such regards might possibly be affected
by the manner in which the situation is framed, as that
influences how people understand risk [24]. The particu-
lar framing favored by the participants was climate
change: a serious threat whose presence is not widely
noticed but which is nonetheless progressing until it
may be too late to remedy, a ‘slowly emerging disaster’.
It has been observed that apocalyptic narratives to de-
scribe the AR problem would be unsuitable for giving
information about AR to the general public [25, 26].
Viens and Littmann [26] list some problematic issues
and we found, in effect, support for these in the FGDs.
Firstly, because of the proliferation of disaster language,
its use could induce ‘disaster fatigue’ in the public, render-
ing the communication less effective. Secondly, talk of
disasters can evoke ideas of the extraordinary use of severe
restrictive measures on antibiotics. Thirdly, there is a risk
that discursive overbidding about AR might induce fatal-
ism or fears, which could stifle behavioral change.
Moreover, when the public needs to consider uncer-
tain, future situations, disaster framing can induce re-
sponses such as a refusal to believe and misbehavior
Table 3 Exemplar quotes from the FGDs
Categories Exemplar quotes Group, participant
Perceived seriousness Q1: “But I think it’s a bit like climate change also in the sense that it’s not so urgent ... you
do not notice the changes now or so, the threats now, but ... when it breaks out… [then]
one may regret it or realize that it is something important. So, it’s not like a tsunami in the
sense that it’s immediate.”
G1, W4
Q4: “…I know too little about these multi-resistant (bacteria), but you’re afraid of it, afraid to
get them and suffer yourself, and afraid that… what would it be like if I couldn’t take any antibiotics?”
G1, W3
Perceived susceptibility Q2: “By contrast, in other countries ... I know quite a lot of people abroad ... they take antibiotics
several times a year. That’s where I feel the problem lies, perhaps not really in Sweden,
but in what the others do.”
G3, W3
Q3: “I’ve thought of this as a reason to just buy Swedish meat because it feels like it’s more
controlled and it’s more certain that there are no drugs left.”
G1, M1
Perceived benefits Q6: “To use them right when they really need to use them, that they don’t do it unnecessarily
so they don’t get any type of anxiety or kind of negative feelings when it’s right to do it.”
G2, M1
Q7: “Yes, it feels like a good compromise. I go abroad but I vaccinate first. Everyone is happy.” G2, W3
Perceived barriers Q5: “... then one pumps up antibiotics more and more when it may be possible to cure in
another way, but because it works so well, one takes antibiotics and it has become natural
to take them on many occasions ... and therefore it has become overused, actually. It has
become something negative for something that has been very good.”
G1, W1
Q8: “To put society’s best before oneself becomes harder and harder.” G1, M3
Q9: “…too easy to take, from the perspective of being too easy for both a doctor who is a
bit fed up with his job and the patient who wants to recover quickly.”
G1, W2
Q10: “[M]y basic problem with antibiotics, it’s still that no one in the world takes responsibility
right now, it seems, and then it doesn’t matter how much we do in Sweden ... well, a little
bit but it’s kind of minimal.”
G3, W3
Perceived self-efficacy Q11: “But if you have such responsibility, it kind of includes some kind of sacrifice… For example,
Thailand is a very popular destination now at Christmas. But Thailand is one of the premier sources
of antibiotic resistance in the world; you should not really go there if one takes this somewhat seriously.”
G4, M1
Q12: “It is difficult to be the one who refrains or stands by the one who refrains, but that ...
yes, it is absolutely necessary.”
G1, M3
Cues to action Q13: “...some global agreement, because then you get more encouraged. […] Feeling that it does
matter the little I do…”
G1, W2
Q14: “Then we of course should… like you state, discipline ourselves in society not to demand…
to the same extent ask for antibiotics as soon we get nauseous or get a cold and so on. So I believe
we are obliged to, as you say, enlightment, to inform, influence people. You can influence in many
ways, not just through repetitive TV commercials, but maybe in many other informative ways.”
G3, M2
Quotes are labelled with G and 1–4 for the group number, W or M for the gender and 1–4 for the participant’s numerical code
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perpetuation [27]. Indeed, the participants expressed
uneasiness about the vagueness of the threat and the
uncertainty of when the disaster would become con-
crete. In contrast, the perception of the likelihood of be-
ing affected by AR increased when they discussed
traveling and food, as the link between actions and po-
tentially harmful consequences was easier to detect and
more tangible. Also from this perspective, then, giving
suitable information proves important.
Individual and collective interests at odds
The participants were not purely self-interested. How-
ever, tension between expected individual gains and
society’s needs emerged from the analysis of the benefits
of and barriers to engaging in judicious behavior. It is
known that antibiotics are thought of in extremely posi-
tive terms [28], so it is not surprising that the main
drivers of participants’ overuse and misuse of antibiotics
were the positive aspects of their use.
Another major, individualistic barrier to better behav-
ior among participants was financial: To stay sick at
home longer without resorting to antibiotics, or buying
more expensive meat, entails an economic loss, which
was discouraging for some participants. In Sweden,
patients try to recover as soon as possible from illness
and go back to work [29], and parents encourage their
children to do the same [30]. Welfare policies, such as a
more generous temporary parental benefit, could help to
overcome these types of economic barriers [29].
Furthermore, we need to strengthen individual duties
that could override such economic concerns. In the
FGDs, values and norms supporting such obligations
were found. There was a consensus in the FGDs that
individual responsibility for public health provides a fun-
damental reason to modify non-judicious behavior. This
was also expressed in moral terms. This finding of indi-
vidual responsibility diverged from observations of other
empirical studies, where the responsibility for tackling
AR was largely or exclusively attributed to others, typic-
ally healthcare staff and authorities [22, 31]. However, it
is consistent with the Swedish public health program
where individual behavior and choice goes together with
solidarity and the notion that people depend on one
another [32].
Conceptually, it is useful to distinguish between egois-
tic and altruistic reasons for judicious behavior. As
egoistic reasons, participants noted possible individual
benefits such as a stronger immune system and reduc-
tion of the ‘no available treatment’ risk. Engaging in
judicious behavior would also entail benefits such as be-
ing aware of contributing to the collective good and be-
ing protected against the shame of being responsible for
non-judicious behavior. Research in fields such as HIV
prevention and cancer clinical trials has highlighted the
important role played by altruistic motivations [33, 34],
but altruism is deficiently accounted for in the HBM
as it rests on the assumption that health-related behavior
should result from one’s own health concerns. However,
previous studies confirm our finding, particularly those on
Fig. 1 Results concerning AR and antibiotics (AB) use mapped through the HBM
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willingness to vaccinate [35, 36], which have shown that
individuals can engage in positive health behavior because
of altruistic beliefs about a health threat to others.
Health communication should empower
One particularly interesting and encouraging finding is
that the partakers largely agreed on the need for
multi-stakeholder involvement and responsibility. Not
only do statutory bodies and clinicians carry duties to
improve the situation; individuals have them too. The
FGD participants stressed that the public should be in-
volved and play a role. Therefore, the public should be
further informed about AR and get involved in the work
to counteract it. These findings are consistent with the
Special Eurobarometer 2013 in which 85% of the Swedish
population agreed that everyone has a role to play to
reduce the risk for human health derived from antimicro-
bial resistance, compared to the EU average of 79% [6].
Individual responsibility involves patients understand-
ing what to ask for when seeing the physician or other
healthcare professionals, as pushy patients are often said
to negatively influence prescribers’ behavior [4, 37].
While previous studies have shown that patients who
obtain prescriptions for antibiotics tend to interpret
these as representing quality of healthcare or concern
for the patient [38], the FGD participants described
overgenerous prescribing primarily as another barrier.
Patients do want to act responsibly, but need support
from ‘the system’ to become aware of what they should
do. A reason for overgenerous prescribing (as some
participants proposed) could be that family physicians
give patients what they want, i.e. antibiotics, because
they are worried about losing their patients to their
colleagues [28, 38].
Despite the efforts carried out in Sweden since the
90s, FGD participants felt that more information is
needed. Previous quantitative studies on the Swedish
population confirm good levels of public awareness, but
also found common confusion about antibiotics use and
AR mechanisms and spread [8, 9]. A study on Swedish
travelers found that low level of knowledge of antibiotic-
resistant bacteria and the spread of resistance influenced
travelers’ behavior and risk-taking, resulting in unaware
exposure to risk situations [10]. The main focus of the
FGDs was the need for accurate AR information from
family physicians. Receiving accurate information
would further individuals’ perception of self-efficacy
and thereby empower patients to do the right thing,
it was believed. This is in accordance with the litera-
ture, where there is substantial evidence for the asso-
ciation between effective communication, self-efficacy,
and health behavior [39].
Interestingly, participants stressed how demotivating it
was for them to think about countries without antibiotic
control strategies and a lack of international coordin-
ation. What they read and hear seems to downplay what
is actually achieved on an international level and empha-
sizes the problems abroad. Initiatives such as the EU
One Health Action Plan against antimicrobial resistance,
the global action plan against AR which was endorsed at
the Sixty-eighth World Health Assembly in May 2015
[2], or that Sweden itself hosts the European Centre for
Disease Prevention and Control (the main EU surveil-
lance system on antimicrobial resistance) and also is the
base of ReAct (an international network working on the
containment of antibiotic resistance since 2005) [40, 41]
largely go unnoticed. The key lesson here is that this
lack of awareness of what is done to counteract AR
seems to work as a powerful barrier to individual action,
and any educational program should be careful to point
to cooperative initiatives and give examples of successful
programs. This would potentially work as an important
cue to action.
Limitations
This study has some limitations. The small sample was
relatively homogeneous with mostly Swedish-speaking
middle class from an urban area. Thus, the results might
not be transferable to other populations and contexts,
particularly those in a rural community or those with
other cultural or ethnic diversity or social class. There-
fore, we welcome more studies that attempt to replicate
our study in a different setting or context.
Conclusions
While lay people strongly and immediately perceive the
severity of AR-related health issues, the way the AR
problem is framed can influence perceived susceptibility
negatively and hinder judicious behavior in relation to
antibiotics use and AR. In communicating or engaging
with the public, it should therefore be emphasized that
AR is a significant public health issue that is already
present and is getting worse. To think of it as some kind
of future dilemma could lessen individual responsibility,
which may reflect negatively on individuals and society.
In addition, giving positive examples of ongoing inter-
national efforts to curb AR could be an important cue to
engage in judicious behavior, as much as the lack of such
examples could be a substantial barrier. People need to
know that such international endeavor exists and feel
that their contribution matter.
People already trust their physicians and rely heavily
on information received from them. This means that if
people could trust their physicians to diligently prescribe
antibiotics, to explain why they do what they do, as well
as inform them on how to act against AR, being aware
of doing well for themselves and others could work as a
powerful cue to action.
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